
Vienna, Austria (21 October 2026) - Cannabis regulators exchanged valuable information on regulatory and control developments, including ongoing legislative reform and active law enforcement investigations into suspected cases of diversion from licit trade into the illicit market in an online meeting hosted by the International Narcotics Control Board (INCB).
With the title “Evolving landscape and regulatory challenges in the cultivation, utilization and consumption of cannabis for medical and scientific purposes”, the meeting brought together over 180 participants from cannabis regulatory agencies from around the globe. Meeting participants welcomed the continuation of the Informal Consultations as a trusted forum for an open exchange of views and updates on the control, monitoring and reporting of cannabis-related activities for medical and scientific purposes. The consultation allowed participants to share up-to-date regulatory and control developments, including ongoing legislative reform and active law enforcement investigations into suspected cases of diversion from licit trade into the illicit market.
The meeting was opened by Dr Cesar Arce, Chair of INCB Working Group on Cannabis-Related Matters, who highlighted the growing number of Member States reporting activities related to medical cannabis, including cultivation, trade, consumption and manufacturing. In 2026, over 20 countries have reported exporting cannabis for medical or scientific purposes in significant amounts. The meeting was closed by Ambassador David Johnson, Chair of the INCB Standing Committee on Estimates, who highlighted the importance of accurate and timely submission of estimated cannabis requirements to the Board. He further confirmed that today’s meeting is a resumption of the series of informal consultations on cannabis that the Board had organized over the past years.
INCB is the independent, quasi-judicial body charged with promoting and monitoring Government compliance with the three international drug control conventions: the 1961 Single Convention on Narcotic Drugs, the 1971 Convention on Psychotropic Substances, and the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. Established by the Single Convention on Narcotic Drugs of 1961, the thirteen members of the Board are elected in a personal capacity by the Economic and Social Council for terms of five years.